Extendicare (TSE:EXE) Stock Price Expected to Rise, BMO Capital Markets Analyst Says

Extendicare (TSE:EXE) had its price objective increased by research analysts at BMO Capital Markets from C$13.50 to C$14.50 in a report released on Monday,BayStreet.CA reports. BMO Capital Markets’ price objective suggests a potential upside of 0.42% from the company’s current price.

Several other analysts also recently commented on the stock. TD Securities raised their price objective on shares of Extendicare from C$10.50 to C$13.00 and gave the company a “hold” rating in a research report on Monday, March 3rd. Cormark upgraded shares of Extendicare to a “moderate buy” rating in a report on Wednesday, February 19th.

Extendicare Stock Performance

EXE stock traded up C$0.11 on Monday, hitting C$14.44. The company had a trading volume of 141,035 shares, compared to its average volume of 190,807. Extendicare has a 12-month low of C$7.10 and a 12-month high of C$15.24. The company has a current ratio of 0.62, a quick ratio of 0.98 and a debt-to-equity ratio of 283.02. The stock’s 50-day simple moving average is C$13.24 and its 200 day simple moving average is C$11.40. The stock has a market cap of C$1.21 billion, a price-to-earnings ratio of 18.41 and a beta of 1.26.

About Extendicare

Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC”) homes and one of the largest private-sector providers of publicly funded home health care services.